Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00457600 · ClinicalTrials.gov registry record

ParentLink: Better and Safer Emergency Care for Children

A clinical trial of Asthma and Otitis Media, sponsored by Boston Children's Hospital.

Completed
Registry status
3,000
Enrollment target
2
Study locations

NCT00457600: Completed study of Asthma and Otitis Media, sponsored by Boston Children's Hospital.

NCT00457600 is a study of Asthma and Otitis Media that has completed, run by Boston Children's Hospital. The registered enrollment target is 3,000 participants, above the 1,555-participant average among 374 other Asthma trials with a reported enrollment target (93% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00457600, a study of Asthma and Otitis Media, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
3,000 participants
Enrollment target
2
Study locations

Study Summary

The emergency department (ED) constitutes a high-risk environment for errors and poor quality of care. Pediatric patients are at increased risk of medical errors. We postulate that implementation of a patient-centered health information technology - ParentLink - can address system-level deficiencies and the unique "just-in-time" information needs of ED physicians and the parents of ill children. The proposed work delivers an innovative product - an electronic interface linked to a pediatric knowledge base that integrates parent-derived data with best practices for safe and effective emergency care across common pediatric disease conditions: otitis media, urinary tract infections, asthma, and head trauma. The study has two aims, the first of which addresses critical gaps in data capture: to evaluate the completeness and accuracy of information on symptoms, disease condition, medications and allergies generated by parents using ParentLink versus information documented by ED physicians and nurses, using structured telephone interviews as a gold standard. The second aim measures the ParentLink's impact on ED patient safety and quality, specifically: a) the error rate for ordering and prescribing of medications during ED care, and b) the percent of ED visits that adhere to national evidence-based guidelines. Parentlink will be rigorously evaluated in a clinical trial at two diverse ED sites and will use a sequential, non-randomized observational design with two intervention and two control periods to measure the effects of ParentLink on data capture and safety and quality of patient care.

Interventions

  • PROCEDURE patient-driven health IT product

Study Locations (2)

Massachusetts

  • Children's Hospital Boston - Boston
  • South Shore Hospital - Weymouth

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2005-06
Est. Completion 2006-07
Boston Children's Hospital

462 total trials

What the finished NCT00457600 record still lists

NCT00457600 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,555-participant average among 374 other Asthma trials with a reported enrollment target (93% higher).

The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which patient-driven health IT product is the first listed.

NCT00457600 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00457600 about?

NCT00457600 is a clinical study titled "ParentLink: Better and Safer Emergency Care for Children". The emergency department (ED) constitutes a high-risk environment for errors and poor quality of care. Pediatric patients are at increased risk of medical errors. We postulate that implementation of a patient-centered health information technology - ParentLink - can address system-level deficiencies...

What is the current status of trial NCT00457600?

This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2005-06. Estimated completion is 2006-07.

What conditions does trial NCT00457600 study?

This clinical trial studies the following conditions: Asthma, Otitis Media, Urinary Tract Infection, Head Injury.

What interventions are being tested in trial NCT00457600?

The interventions under investigation include: patient-driven health IT product (PROCEDURE).

Who is sponsoring clinical trial NCT00457600?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00457600 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00457600's enrollment target sits among peer trials

3,000 16th of 374 higher than 357 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00457600, the US trial registry maintained by the National Library of Medicine. NCT00457600 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.